awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47110069-FDF03C00-8F9D-4251-9669-6F6171FAAE4D
Q47110069-FDF03C00-8F9D-4251-9669-6F6171FAAE4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47110069-FDF03C00-8F9D-4251-9669-6F6171FAAE4D
Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort Analysis.
P2860
Q47110069-FDF03C00-8F9D-4251-9669-6F6171FAAE4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47110069-FDF03C00-8F9D-4251-9669-6F6171FAAE4D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a9905f137eb59062a442985c8f8c3cc98713730
P2860
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.